Living with an Autoimmune Disease in India: A Patient’s Guide to AS & RA

Will I be able to live a normal life? This question arises before almost any other, once a patient is diagnosed with ankylosing spondylitis or rheumatoid arthritis. For most patients, the honest answer is yes, with consistent management and the right support around you. This guide covers what that actually takes in India: daily symptom management, the real cost picture, the mental health side rarely discussed openly, and how work and relationships fit into a life that includes AS or RA without being defined by it.

Normal doesn’t mean unchanged. It means managed well enough that the disease stops running the show. That distinction matters, and this guide walks through exactly how patients across India get there.

Every section in this patient’s guide draws on India-specific, peer-reviewed data rather than general international figures, because the cost, insurance, and specialist-access picture in India looks meaningfully different from what patients face elsewhere. Where a claim touches your specific treatment, insurance, or family planning decisions, treat it as a starting point for a conversation with your rheumatologist, not a replacement for one.

What “Living Normally” With AS or RA Actually Means

Living normally with a chronic autoimmune condition rarely means symptom-free forever. It means reaching a stage that rheumatologists call for remission. It is a situation with long stretches of low or no disease activity, achieved through consistent medication, physical therapy, and movement. Remission is genuinely achievable for most patients, particularly with early treatment. However, it requires ongoing management rather than a one-time fix.

As an individual suffering from RA or AS, you are not managing something rare or unusual. According to Indian Journal of Rheumatology, AS affects an estimated 0.03% of India’s population, based on pooled survey data, while the broader spondyloarthritis family of conditions affects roughly 7 to 9 per 10,000 people. This means there are hundreds of thousands of people across the country with similar doubts and questions that you are having right now.

What remission actually looks like depends on person to person.

• For some patients, it means stiffness that fades by mid-morning instead of lasting all day.
• For others, it means going months between flares instead of weeks.

You cannot expect an identical outcome for every patient. Instead, it’s finding your own stable baseline and building a routine that protects it. Tracking your own pattern, rather than comparing your progress to someone else’s timeline, will give you more accurate and less discouraging picture of how treatment works.

Your Daily Management Toolkit: What Actually Keeps Symptoms Down

Here we recommend four habits to help you the most in keeping your AS and RA symptoms manageable day to day:

Medication adherence comes first, since skipping doses to save money or out of convenience raises the risk of a flare that costs far more later, both physically and financially.

• Posture and stretching routine: It matters specifically for AS, since extension-based stretches counter the forward-stooped posture the disease can cause over years of untreated inflammation. Building these into a fixed daily routine, rather than relying on willpower each morning, is what makes them sustainable over the years rather than weeks.
• Low-impact exercise: It includes swimming, yoga, and walking, keeping joints mobile without the impact that running or heavy weight training can add.
• Sleep positioning: It also helps manage the morning stiffness that many AS patients describe as their worst symptom of the day, since sleeping on your back with proper spinal support reduces overnight stiffening.
• Balanced diet: This plays a supporting role rather than a curative one, despite what some online claims suggest. No specific diet reverses AS or RA, but an anti-inflammatory eating pattern, rich in vegetables, whole grains, and omega-3 sources like fish, supports overall symptom management alongside medication.

Be cautious of any diet or supplement claiming to replace your prescribed treatment entirely and raise dietary changes with your doctor rather than adopting them on advice from unverified sources. Social media wellness trends move faster than clinical evidence, and a claim of popularity online says nothing about whether it’s safe for your specific treatment plan. None of this replaces your treatment plan; it supports it. Raise each of these habits directly with your rheumatologist rather than adjust your regimen on your own.

Cost of living with AS or RA in India

A lot of patients are worried about the cost involved in the treatment rather than the disease itself. We strongly feel that this concern deserves a straight answer.

Medicines:

• According to Indian Journal of Rheumatology, the average annual cost of managing AS or RA with conventional, non-biologic therapy runs ₹41,379 for AS and ₹51,741 for RA per patient.
• Patients who progress to biologic treatment face several multiples higher, since this figure covers conventional therapy alone.
• That cost of biologics pushed 6.67% of AS households and 14.92% of RA households into exorbitant health expenditure.

That gap between conventional and biologic costs is worth understanding early, since many patients eventually need biologics once conventional drugs stop controlling disease activity on their own.

Insurance:

• Insurance coverage in India remains inconsistent for both RA and AS conditions.
• Some insurers cover hospitalization for severe flares or joint replacement surgery, and a small number include advanced rheumatoid arthritis under critical-illness riders.
• Routine outpatient visits and biologic medication are rarely covered in full.
• Patients and their family members are advised to review specific policy terms for chronic, pre-existing conditions well in advance to help you save considerable stress at the time of filing the claim.
• Also check out for policies that apply to a multi-year waiting period before pre-existing condition claims become payable at all.

Though the numbers are real, they don’t tell the whole story. Here are some things worth knowing about the costs:

• Biosimilars often cost meaningfully less than original biologic drugs while meeting the same clinical standards.
• Several hospitals run patient-assistance programs that reduce per-dose costs for eligible patients.
• Joining patient support groups can help patients connect with people in the same journey, find out about recent research and evolving medicines and treatments.

Planning with your rheumatologist, rather than discovering costs of mid-treatment, changes how manageable this burden feels in practice.

The Mental Health Side Nobody Warns You About

Chronic pain conditions carry well-documented, elevated rates of anxiety and low mood, and financial or work-related stress about the condition compounds this rather than sitting separately from it. Patients often describe this as a second, parallel weight: the disease itself, and the ongoing effort of managing life around it.

The flare tends to show up in specific moments rather than as one constant feeling:

• The week before the treatment cost is due
• The morning a flare cancels plans you’d already made
• The quiet frustration of explaining an invisible illness to someone who only sees you on a good day is a great day.

Naming these moments as part of managing the disease, not as separate personal struggles, will make it easier for you to talk about, both with a therapist and with the people closest to you. This experience is common, not a personal failing, and it deserves the same attention as your physical symptoms.

Rheumatologists on the panel of Antardhwani, who lead the doctor-patient sessions featured on our YouTube channel, consistently point out that patients who address the emotional weight of a chronic diagnosis alongside physical treatment tend to stay more consistent with their medication and daily management overall.

Work, Relationships, and What to Tell People

If research is to be believed, average work-productivity impairment among AS and RA patients reaches close to 50%, irrespective of previous or existing employment status. It also means that most patients continue full careers with AS or RA, particularly with early treatment. Flare-related absenteeism and reduced productivity are real, which is why it is important to plan things in advance, not hiding it, making proactive planning more useful than reactive damage control.

Building the Support System That Makes This Sustainable

Patients who connect with other patients managing the same condition report better day-to-day coping. They also have practical knowledge like which foods trigger flares or which employers have been accommodating, spread faster through community than through a single doctor’s visit.

This matters more in India specifically as less than 1,000 practicing rheumatologists serve a population of 1.4 billion, which means much of the support between appointments falls to community and self-management.

That specialist shortage also means appointment gaps of several months are common in many cities, particularly outside major metros. A community of other patients doesn’t replace that specialist relationship, but it fills the space between visits with practical, lived experience: what a new medication side effect actually feels like, how someone else navigated a difficult employer conversation, or simply confirmation that a bad week doesn’t mean treatment has failed.

To read more about autoimmune diseases rising in young Indian.

Will your life still be normal? Normal doesn’t mean unchanged. It means managed, supported, and still, yours to build, with the right medical care and the right people around you. Every step in this guide, from daily habits to community support, exists to make that version of normal genuinely achievable. The path looks different for every patient, but the destination, a life that includes AS or RA without being ruled by it, is reachable for most people who commit to consistent care.